These findings suggest that LAPTM4B and SLC7A11 are coordinately involved in regulating ferroptosis in NSCLC patients, which further influences the progression of NSCLC and the survival probability of patients. This evidence concerns the gene LAPTM4B and non-small cell lung carcinoma.